Sciegen Pharmaceuticals India Private Limited - Company Profile

It is a pharma private limited company based in Shaikpet, Telangana, India, established in 2013.
2013 Shaikpet, Telangana, India Active
Last Updated:
About Sciegen Pharmaceuticals India Private Limited

Sciegen Pharmaceuticals India Private Limited, a active private limited company, was established on 28 January 2013 in Shaikpet, Telangana, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U24240TG2013PTC085471. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹9.00 Cr and a paid-up capital of ₹2.00 Cr.

Formerly known as Pmr Energy Private Limited. It upholds a compliant status. Employing 45 professional, Its leadership includes Saketh Reddy Pailla (Director), Venkata Siva Reddy Pallempalli (Director), Alla Bhaskara Reddy (Director). Past directors included Mohan Reddy Patalolla, Shilpasri Reddy Pailla, Bhagwant Reddy Gantla. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No 238, Azura Heights, Road No 35, 100 Feet Road, Ayyappa Society (Survey Of India), Shaikpet, Telangana, 500081.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24240TG2013PTC085471

  • Registration Number

    085471

  • Incorporation Date

    28 January 2013

  • Authorized Capital

    ₹9.00 Cr

  • Paid-Up Capital

    ₹2.00 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 9.00 Cr
  • Paid Up Capital ₹ 2.00 Cr
  • Company Age 13 Year, 1 Month
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** 15.55%
  • Profit Growth **** -74.73%
  • Ebitda **** -14.69%
  • Net Worth 276.67%
  • Total Assets **** 204.22%
Company report

Sciegen Pharmaceuticals India Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sciegen Pharmaceuticals India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sciegen Pharmaceuticals India Private Limited?
Current Directors
Name Designation Appointment Date Status
Saketh Reddy Pailla Director 29 Apr 2023 Current
Venkata Siva Reddy Pallempalli Director 10 Aug 2018 Current
Alla Bhaskara Reddy Director 02 Oct 2017 Current
Pailla Malla Reddy Director 28 Dec 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 06 Feb 2016 Past
Pramod Abcsdd Additional Director 30 Sep 2016 Past
Pramod Abcsdd Director 06 Feb 2016 Past
Pramod Abcsdd Additional Director 12 Sep 2018 Past
Pramod Abcsdd Director 19 Jun 2015 Past
Pramod Abcsdd Additional Director 30 Sep 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sciegen Pharmaceuticals India.

Sciegen Pharmaceuticals India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.55% increase. The company also saw a substantial fall in profitability, with a 74.73% decrease in profit. The company's net worth Soared by an impressive increase of 276.67%.

Sciegen Pharmaceuticals India revenue growth over time
Sciegen Pharmaceuticals India profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
15.55%
*******
*******
*******
*******
Revenue from Operations
*******
19.43%
*******
*******
*******
*******
Total Assets
*******
204.22%
*******
*******
*******
*******
Profit or Loss
*******
-74.73%
*******
*******
*******
*******
Net Worth
*******
276.67%
*******
*******
*******
*******
EBITDA
*******
-14.69%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sciegen Pharmaceuticals India?

Unlock access to Sciegen Pharmaceuticals India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Sciegen Pharmaceuticals India?

Sciegen Pharmaceuticals India has a workforce of 45 employees as of Oct 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sciegen Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sciegen Pharmaceuticals India's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sciegen Pharmaceuticals India
Recent Activity within the Organization
  • Annual General Meeting

    Sciegen Pharmaceuticals India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Sciegen Pharmaceuticals India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.

  • Director Appointment

    Saketh Reddy Pailla was appointed as a Director was appointed as a Director on 29 Apr 2023 & has been associated with this company since 2 years 10 months . was recorded as a recent event.

  • Director Appointment

    Progress on Venkata Siva Reddy Pallempalli was appointed as a Director was appointed as a Director on 10 Aug 2018 & has been associated with this company since 7 years 6 months . was documented.

  • Director Appointment

    The activity Alla Bhaskara Reddy was appointed as a Director was appointed as a Director on 02 Oct 2017 & has been associated with this company since 8 years 5 months . was completed.

  • Director Appointment

    Pailla Malla Reddy was appointed as a Director was appointed as a Director on 28 Dec 2015 & has been associated with this company since 10 years 2 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sciegen Pharmaceuticals India Private Limited?

The CIN of Sciegen Pharmaceuticals India Private Limited is U24240TG2013PTC085471.

Where is Sciegen Pharmaceuticals India Private Limited headquartered?

Sciegen Pharmaceuticals India Private Limited is headquartered at Plot No 238, Azura Heights, Road No 35, 100 Feet Road, Ayyappa Society (Survey Of India), Shaikpet, Telangana, 500081.

When was Sciegen Pharmaceuticals India Private Limited incorporated?

Sciegen Pharmaceuticals India Private Limited was incorporated on 28 January 2013.

Who are the current directors of Sciegen Pharmaceuticals India Private Limited?

The current directors of Sciegen Pharmaceuticals India Private Limited are

What is the primary industry of Sciegen Pharmaceuticals India Private Limited?

The primary industry of Sciegen Pharmaceuticals India Private Limited is Professional, Scientific And Technical.

Is Sciegen Pharmaceuticals India Private Limited a listed company?

Sciegen Pharmaceuticals India Private Limited is unlisted.

What is the capital structure of Sciegen Pharmaceuticals India Private Limited?

The authorized capital of Sciegen Pharmaceuticals India Private Limited is ₹9.00 Cr, and the paid-up capital is ₹2.00 Cr.

What is the compliance status of Sciegen Pharmaceuticals India Private Limited?

The compliance status of Sciegen Pharmaceuticals India Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available